Milestone Pharmaceuticals (MIST)

• Market cap: $229M
• 1 day: 0%
• 5 days: 8.03%
• 1 month: 45.41%
• 3 months: 46.2%
• 6 months: 55.49%
• Year to date: 23.96%
• 1 year: 34.5%
• 5 years: -58.62%
• 10 years: -82.5%
• Sector: Healthcare
• Industry: Biotechnology

About: Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Employees: 33